SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?


To: yosi s who wrote (719)4/23/1999 1:06:00 PM
From: David Israel-Rosen  Read Replies (1) | Respond to of 1386
 
Check out the unofficial web site of Pharmos at:

geocities.com



To: yosi s who wrote (719)4/23/1999 2:11:00 PM
From: LLCF  Read Replies (1) | Respond to of 1386
 
I would think that the company would want to try and preserve cash and get HU-211 to market... won't they burn quite a bit of cash without Tamaxiphene?? The way it looks to me is they could go through their "upfront" before HU-211 gets to market unless the partner pays for the whole thing. Am I being too pessimistic here?

DAK